Droplet-Microfluidic-Based Promoter Engineering and Expression Fine-Tuning for Improved Erythromycin Production in Saccharopolyspora erythraea NRRL 23338

Erythromycin is a clinically important drug produced by the rare actinomycete Saccharopolyspora erythraea. In the wide-type erythromycin producer S. erythraea NRRL 23338, there is a lack of systematical method for promoter engineering as well as a well-characterized promoter panel for comprehensive metabolic engineering. Here we demonstrated a systematical promoter acquiring process including promoter characterization, engineering and high-throughput screening by the droplet-microfluidic based platform in S. erythraea NRRL 23338, and rapidly obtained a panel of promoters with 21.5-fold strength variation for expression fine-tuning in the native host. By comparative qRT-PCR of S. erythraea NRRL 23338 and a high-producing strain S0, potential limiting enzymes were identified and overexpressed individually using two screened synthetic promoters. As a result, erythromycin production in the native host was improved by as high as 137.24 folds by combinational gene overexpression. This work enriches the accessible regulatory elements in the important erythromycin-producing strain S. erythraea NRRL 23338, and also provides a rapid and systematic research paradigm of promoter engineering and expression fine-tuning in the similar filamentous actinomycete hosts.

[1]  Hahk-Soo Kang,et al.  Top-down synthetic biology approach for titer improvement of clinically important antibiotic daptomycin in Streptomyces roseosporus. , 2021, Metabolic engineering.

[2]  Qing-ting Bu,et al.  Rational engineering strategies for achieving high-yield, high-quality and high-stability of natural product production in actinomycetes. , 2021, Metabolic engineering.

[3]  R. Tu,et al.  Droplet-based microfluidic platform for high-throughput screening of Streptomyces , 2021, Communications Biology.

[4]  R. Tu,et al.  Antisense RNA Interference-Enhanced CRISPR/Cas9 Base Editing Method for Improving Base Editing Efficiency in Streptomyces lividans 66. , 2021, ACS synthetic biology.

[5]  Z. Deng,et al.  Engineering the Erythromycin-Producing Strain Saccharopolyspora erythraea HOE107 for the Heterologous Production of Polyketide Antibiotics , 2020, Frontiers in Microbiology.

[6]  Wen-Guang Wang,et al.  Strategies for Discovering New Antibiotics from Bacteria in the Post-Genomic Era , 2020, Current Microbiology.

[7]  Yinhua Lu,et al.  Recent Advances in Synthetic Biology Approaches to Optimize Production of Bioactive Natural Products in Actinobacteria , 2019, Front. Microbiol..

[8]  A. Feliz,et al.  A Review of the Microbial Production of Bioactive Natural Products and Biologics , 2019, Front. Microbiol..

[9]  B. Ye,et al.  A CRISPR-Cas9 Strategy for Activating the Saccharopolyspora erythraea Erythromycin Biosynthetic Gene Cluster with Knock-in Bidirectional Promoters. , 2019, ACS synthetic biology.

[10]  G. Niu,et al.  Regulation of antibiotic biosynthesis in actinomycetes: Perspectives and challenges , 2018, Synthetic and systems biotechnology.

[11]  Hahk-Soo Kang,et al.  Library of Synthetic Streptomyces Regulatory Sequences for Use in Promoter Engineering of Natural Product Biosynthetic Gene Clusters. , 2018, ACS synthetic biology.

[12]  Jing Liang,et al.  Genome-scale engineering of Saccharomyces cerevisiae with single-nucleotide precision , 2018, Nature Biotechnology.

[13]  B. Ye,et al.  High GC Content Cas9-Mediated Genome-Editing and Biosynthetic Gene Cluster Activation in Saccharopolyspora erythraea. , 2018, ACS synthetic biology.

[14]  A. Jaramillo,et al.  Using promoter libraries to reduce metabolic burden due to plasmid-encoded proteins in recombinant Escherichia coli. , 2016, New biotechnology.

[15]  Weishan Wang,et al.  Genome-wide identification and evaluation of constitutive promoters in streptomycetes , 2015, Microbial Cell Factories.

[16]  G. Challis,et al.  Discovery of microbial natural products by activation of silent biosynthetic gene clusters , 2015, Nature Reviews Microbiology.

[17]  Huimin Zhao,et al.  Systematic Identification of a Panel of Strong Constitutive Promoters from Streptomyces albus. , 2015, ACS synthetic biology.

[18]  Huimin Zhao,et al.  High-Efficiency Multiplex Genome Editing of Streptomyces Species Using an Engineered CRISPR/Cas System , 2014, ACS synthetic biology.

[19]  Carlos Olano,et al.  Activation and identification of five clusters for secondary metabolites in Streptomyces albus J1074 , 2014, Microbial biotechnology.

[20]  H. Petković,et al.  SACE_5599, a putative regulatory protein, is involved in morphological differentiation and erythromycin production in Saccharopolyspora erythraea , 2013, Microbial Cell Factories.

[21]  Huimin Zhao,et al.  Refactoring the silent spectinabilin gene cluster using a plug-and-play scaffold. , 2013, ACS synthetic biology.

[22]  Yixue Li,et al.  Systems perspectives on erythromycin biosynthesis by comparative genomic and transcriptomic analyses of S. erythraea E3 and NRRL23338 strains , 2013, BMC Genomics.

[23]  Pietro Alifano,et al.  Comparative genomics and transcriptional profiles of Saccharopolyspora erythraea NRRL 2338 and a classically improved erythromycin over-producing strain , 2012, Microbial Cell Factories.

[24]  Herbert M Sauro,et al.  Designing and engineering evolutionary robust genetic circuits , 2010, Journal of biological engineering.

[25]  Young Ji Yoo,et al.  Genetic engineering of macrolide biosynthesis: past advances, current state, and future prospects , 2010, Applied Microbiology and Biotechnology.

[26]  Lubos Klucar,et al.  phiSITE: database of gene regulation in bacteriophages , 2009, Nucleic Acids Res..

[27]  Markiyan Samborskyy,et al.  Complete genome sequence of the erythromycin-producing bacterium Saccharopolyspora erythraea NRRL23338 , 2007, Nature Biotechnology.

[28]  V. Danilenko,et al.  Biogenesis and Regulation of Biosynthesis of Erythromycins in Saccharopolyspora erythraea , 2004, Applied Biochemistry and Microbiology.

[29]  C. Kao,et al.  Reverse engineering of industrial pharmaceutical-producing actinomycete strains using DNA microarrays. , 2004, Metabolic engineering.

[30]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[31]  C R Hutchinson,et al.  Sequencing and mutagenesis of genes from the erythromycin biosynthetic gene cluster of Saccharopolyspora erythraea that are involved in L-mycarose and D-desosamine production. , 1997, Microbiology.

[32]  T. Kieser.  Practical streptomyces genetics , 2000 .

[33]  M. Bibb,et al.  Cloning and analysis of the promoter region of the erythromycin resistance gene (ermE) of Streptomyces erythraeus. , 1985, Gene.